Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse ...

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple ...

Cathie Wood’s ARK ETF published their daily trades for Wednesday, February 18th, 2026, revealing significant activity in the biotech and tech sectors. The largest transaction of the day was the ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached its second release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

The United States and Iran have reached an understanding on the “guiding principles” in nuclear talks, Tehran’s foreign minister said Tuesday, though he cautioned that work still needs to be done to ...